Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1183

Showing 1-25 of 1183 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1408
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 151-172
Closed Access | Times Cited: 1135
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 571
Interleukins in cancer: from biology to therapy
Daria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 481-499
Open Access | Times Cited: 532
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 509
The inflammatory pathogenesis of colorectal cancer
Mark R. Schmitt, Florian R. Greten
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 653-667
Closed Access | Times Cited: 473
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 453
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam, Romina E. Araya, April Huang, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5338-5356.e21
Open Access | Times Cited: 358
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 251
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
Feng Li, Caichen Li, Xiuyu Cai, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101134-101134
Open Access | Times Cited: 250
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 245
CD4+ T cells in cancer
Daniel E. Speiser, Obinna Chijioke, Karin Schaeuble, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 317-329
Closed Access | Times Cited: 231
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Ruben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science (2023) Vol. 381, Iss. 6657, pp. 515-524
Open Access | Times Cited: 223
M1/M2 macrophages and their overlaps – myth or reality?
Zuzana Střížová, Iva Benešová, Robin Bartolini, et al.
Clinical Science (2023) Vol. 137, Iss. 15, pp. 1067-1093
Open Access | Times Cited: 178
Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
Jia‐Ren Lin, Shu Wang, Shannon Coy, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 363-381.e19
Open Access | Times Cited: 169
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
Dongqiang Zeng, Jiani Wu, Hui Luo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002467-e002467
Open Access | Times Cited: 163
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Carla Montironi, Florian Castet, Philipp K. Haber, et al.
Gut (2022) Vol. 72, Iss. 1, pp. 129-140
Open Access | Times Cited: 158
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
Paolo Vignali, Kristin DePeaux, McLane J. Watson, et al.
Nature Immunology (2022) Vol. 24, Iss. 2, pp. 267-279
Open Access | Times Cited: 153
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Jérémy Goc, Mengze Lv, Nicholas J. Bessman, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 5015-5030.e16
Open Access | Times Cited: 138
Germline genetic contribution to the immune landscape of cancer
Rosalyn W. Sayaman, Mohamad Saad, Vésteinn Thórsson, et al.
Immunity (2021) Vol. 54, Iss. 2, pp. 367-386.e8
Open Access | Times Cited: 129
A signature for pan-cancer prognosis based on neutrophil extracellular traps
Yi Zhang, Liping Guo, Qichen Dai, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004210-e004210
Open Access | Times Cited: 127
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Nathalie Scholler, Régis Perbost, Frederick L. Locke, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1872-1882
Open Access | Times Cited: 125
ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation
Yuanqin Yang, Meng Wu, Dongqing Cao, et al.
Science Advances (2021) Vol. 7, Iss. 41
Open Access | Times Cited: 122
Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
Ziyi Bai, Yao Zhou, Zifan Ye, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 113
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 111
Page 1 - Next Page

Scroll to top